Visceral Leishmaniasis and Post-kala-azar Dermal Leishmaniasis

Visceral Leishmaniasis and Post-kala-azar Dermal Leishmaniasis

Pathogenesis, Treatment and Disease Control

Kumar, Ashish; Singh, Veer

Taylor & Francis Ltd

03/2025

272

Dura

9781032633053

Pré-lançamento - envio 15 a 20 dias após a sua edição

Descrição não disponível.
Chapter 1 General Introduction of visceral leishmaniasis. Chapter 2 Geographical distribution of VL and PKDL in India. Chapter 3 Visceral leishmaniasis as a public health problem in India: Action toward its elimination. Chapter 4 Pathogenesis of Visceral Leishmaniasis. Chapter 5 A current scenario of drug discovery against visceral leishmaniasis. Chapter 6 Major challenges in visceral leishmaniasis treatment. Chapter 7 Post-Kala-azar Dermal Leishmaniasis Development from Visceral Leishmaniasis. Chapter 8 Symptoms and diagnosis of visceral leishmaniasis and post kala-azar dermal leishmaniasis. Chapter 9 Molecular Mechanism of PKDL Development. Chapter 10 Immunopathogenesis of Visceral Leishmaniasis and Post-Kala azar Dermal Leishmaniasis. Chapter 11 A recent update on Visceral Leishmaniasis, and Post Kala-azar Dermal Leishmaniasis: Epidemiology, Diagnosis, and Treatments. Chapter 12 Review the existing control measures for VL and PKDL: Innovative vector control approaches, case management, vaccine development and community education. Chapter 13 Public Health Implications and Challenges of VL and PKDL. Chapter 14 Role of Environmental Factors on the Development of PKDL. Chapter 15 Arsenic and antimony toxicity in drinking water and their role in the development of PKDL. Chapter 16 Government policies toward providing safe drinking water to the public and current updates. Chapter 17 Factor influencing the development of Post-Kala-azar dermal Leishmaniasis.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Visceral leishmaniasis;Post-kala-azar dermal leishmaniasis;Molecular mechanism of PKDL development;Arsenic contamination and leishmaniasis;Disease control;Potential drugs